Analyze Diet
Journal of veterinary pharmacology and therapeutics1995; 18(1); 47-53; doi: 10.1111/j.1365-2885.1995.tb00550.x

Pharmacokinetics of trimethoprim/sulphachlorpyridazine in horses after oral, nasogastric and intravenous administration.

Abstract: In the present study, the pharmacokinetic parameters of a trimethoprim/sulphachlorpyridazine preparation following intravenous administration, administration by nasogastric tube and administration with concentrate were determined in the horse. Eight adult horses were dosed at 1 week intervals in a sequentially designed study at a dose of 5 mg/kg trimethoprim (TMP) and 25 mg/kg sulphachlorpyridazine (SCP) on all occasions. Plasma concentrations of both drugs were measured serially for 48 h. Pharmacokinetic parameters of clinical importance (distribution and elimination half-lives, clearance, bioavailability, volume of distribution) were determined both for TMP and SCP. Following intravenous administration, the volume of distribution at steady-state (Vd(ss)) was significantly larger for TMP (1.51 +/- 0.25 L/kg than for SCP (0.26 +/- 0.05 L/kg. The clearance was 7.73 +/- 2.26 mL/min.kg for TMP and 2.64 +/- 0.48 mL/min.kg for SCP. For both TMP and SCP, mean peak plasma concentrations (Cmax) and the bioavailabilities (F) were reduced significantly when the drugs were mixed with concentrate (ct) as compared with those after nasogastric administration (ngt) (Fct = 44.3 +/- 10.7% vs. Fngt = 68.3 +/- 12.5% for TMP; Fct = 46.3 +/- 8.9% vs. Fngt = 67.3 +/- 13.7% for SCP). Following the administration of TMP and SCP mixed with concentrate, the plasma concentration-time curves showed a biphasic absorption pattern in all horses. The first peak occurred 1-2 h and the second peak 8-10 h after administration of the combination preparation.(ABSTRACT TRUNCATED AT 250 WORDS)
Publication Date: 1995-02-01 PubMed ID: 7752306DOI: 10.1111/j.1365-2885.1995.tb00550.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research paper explores the pharmacokinetic properties (how a drug is absorbed, distributed, metabolized, and excreted in the body) of a combined drug treatment of trimethoprim (TMP) and sulphachlorpyridazine (SCP) in horses. The study compares the results when the drugs are administered through different routes: orally (mixed with feed), nasogastrically (through a tube into the stomach), and intravenously (into the bloodstream).

Research Methodology

  • The study involved eight adult horses monitored over a week.
  • The horses were given a dosage of 5 mg/kg of TMP and 25 mg/kg of SCP, administered via various methods.
  • The plasma concentrations of the drugs were measured over a period of 48 hours.
  • Relevant pharmacokinetic parameters (distribution and elimination half-lives, clearance rate, bioavailability, and volume of distribution) were determined for both TMP and SCP.

Results

  • After intravenous administration, the volume of distribution at steady-state (Vd(ss)) was significantly larger for TMP than for SCP.
  • The clearance rates were 7.73 +/- 2.26 mL/min.kg for TMP and 2.64 +/- 0.48 mL/min.kg for SCP.
  • Peak plasma concentrations (Cmax) and the bioavailabilities (F) of both drugs were significantly reduced when mixed with feed (concentrate) compared to nasogastric administration.
  • Plasma concentration-time curves after feed administration displayed a biphasic absorption pattern, with the first peak happening 1-2 hours after administration, and the second peak 8-10 hours later.

Conclusion

Based on the research conducted, the administered method significantly impacts the pharmacokinetic properties of TMP and SCP in horses. In particular, the drug combination’s bioavailability was reduced when the drugs were mixed with concentrate compared to administering them via a nasogastric tube. This work has broad implications for how TMP and SCP – and potentially other drugs – are administered in veterinary medicine for maximized effect.

Cite This Article

APA
van Duijkeren E, Vulto AG, Sloet van Oldruitenborgh-Oosterbaan MM, Kessels BG, van Miert AS, Breukink HJ. (1995). Pharmacokinetics of trimethoprim/sulphachlorpyridazine in horses after oral, nasogastric and intravenous administration. J Vet Pharmacol Ther, 18(1), 47-53. https://doi.org/10.1111/j.1365-2885.1995.tb00550.x

Publication

ISSN: 0140-7783
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 18
Issue: 1
Pages: 47-53

Researcher Affiliations

van Duijkeren, E
  • Department of Large Animal Medicine and Nutrition, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.
Vulto, A G
    Sloet van Oldruitenborgh-Oosterbaan, M M
      Kessels, B G
        van Miert, A S
          Breukink, H J

            MeSH Terms

            • Absorption
            • Administration, Oral
            • Animals
            • Biological Availability
            • Chromatography, High Pressure Liquid
            • Computer Simulation
            • Female
            • Half-Life
            • Horses / metabolism
            • Injections, Intravenous / veterinary
            • Intubation, Gastrointestinal / veterinary
            • Male
            • Reference Standards
            • Regression Analysis
            • Sulfachlorpyridazine / administration & dosage
            • Sulfachlorpyridazine / blood
            • Sulfachlorpyridazine / pharmacokinetics
            • Trimethoprim / administration & dosage
            • Trimethoprim / blood
            • Trimethoprim / pharmacokinetics

            Citations

            This article has been cited 2 times.
            1. Sykes BW, Sykes KM, Hallowell GD. Administration of trimethoprim-sulphadimidine does not improve healing of glandular gastric ulceration in horses receiving omeprazole: a randomised, blinded, clinical study. BMC Vet Res 2014 Aug 23;10:180.
              doi: 10.1186/s12917-014-0180-0pubmed: 25927827google scholar: lookup
            2. Thomson ACS, McCarrel TM, Zakharov A, Gomez B, Lyubimov A, Schwark WS, Mallicote MF, Portela DA, Bisiau AL, Wakshlag JJ. Pharmacokinetics and tolerability of single-dose enteral cannabidiol and cannabidiolic acid rich hemp in horses (Equus caballus). Front Vet Sci 2024;11:1356463.
              doi: 10.3389/fvets.2024.1356463pubmed: 38681854google scholar: lookup